Evidence map›Paper›PMID 28797289›Full record

ArticleLipids in health and disease2017

Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon.

Steve Raoul Ngongang Noumegni, Jobert Richie Nansseu, Vicky Jocelyne Moor Ama, Jean Joel Bigna, Felix Kembe Assah, Magellan Guewo-Fokeng, Steve Leumi, Jean-Claude Katte, Mesmin Dehayem, Andre Pascal Kengne and 1 more

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Steve Raoul Ngongang NoumegniFaculty of Medicine and Biomedical Sciences, University of Yaoundé 1, PO Box 1364, Yaoundé, Cameroon. stevenoumegni91@yahoo.com.ORCID http://orcid.org/0000-0002-0583-005X
Jobert Richie NansseuDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, PO Box 1364, Yaoundé, Cameroon.
Vicky Jocelyne Moor AmaDepartment of Biochemistry and Physiological Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, PO Box 1364, Yaoundé, Cameroon.
Jean Joel BignaFaculty of Medicine, University of Paris Sud XI, 63 Av Gabriel Péri, Le Kremlin Bicêtre, France.
Felix Kembe AssahDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, PO Box 1364, Yaoundé, Cameroon.
Magellan Guewo-FokengDepartment of Biochemistry, Faculty of Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Steve LeumiDepartment of Biochemistry, Faculty of Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Jean-Claude KatteNational Obesity Center, Yaoundé Central Hospital, PO Box 87, Yaoundé, Cameroon.
Mesmin DehayemNational Obesity Center, Yaoundé Central Hospital, PO Box 87, Yaoundé, Cameroon.
Andre Pascal KengneNon-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, 7505, South Africa.
Eugene SobngwiLaboratory of Molecular Medicine and Metabolism, Biotechnology Center, University of Yaoundé 1, Yaoundé, Cameroon.
Université de Yaoundé I · CMCentral Hospital of Yaoundé · CMUniversité Paris-Sud · FRSouth African Medical Research Council · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known on the magnitude and correlates of insulin resistance in HIV-infected people in Africa. We determined the prevalence of insulin resistance and investigated associated factors in HIV-infected adult Cameroonians.

methodsWe conducted a cross-sectional study at the Yaoundé Central Hospital, Cameroon; during which we enrolled HIV-infected people aged 30 to 74 years with no previous history of cardiovascular disease. An homeostatic model assessment of insulin resistance (HOMA-IR) like index served to assess insulin sensitivity with insulin resistance defined by values of 2.1 or higher.

resultsWe included 452 patients (20% men). Their mean age was 44.4 ± 9.8 years and 88.5% of them were on antiretroviral therapy (93.3% on first line regimen including Zidovudine, lamivudine and Efavirenz/Nevirapine). Of all participants, 28.5% were overweight, 19.5% had obesity and 2.0% had diabetes. The prevalence of insulin resistance was 47.3% without any difference between patients on ART and those ART-naïve (48.5% vs. 38.5%; p = 0.480). Obesity was the only factor independently associated with insulin resistance (adjusted odds ratio: 2.28; 95% confidence interval: 1.10-4.72).

conclusionInsulin resistance is present in nearly half of HIV-infected patients in Cameroon despite a low prevalence rate of diabetes, and is associated with obesity.

Indexed as

Insulin ResistanceAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCameroonCholesterol, HDLCholesterol, LDLCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHIV InfectionsHumansMaleMiddle AgedObesityOdds RatioAnti-HIV AgentsCholesterol, HDLCholesterol, LDLTriglyceridesCameroonHIVHOMA-IRInsulin resistance

Identifiers

PMID28797289
PMCPMC5553591
OpenAlexW2743218784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.